SLC7A11/xCT Rekombinanter Antikörper

SLC7A11/xCT Rekombinant Antikörper für IF/ICC, FC (Intra), ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human und mehr (1)

Anwendung

WB, IF/ICC, FC (Intra), ELISA

Konjugation

Unkonjugiert

Publikationen(3)

CloneNo.

230227C5

Kat-Nr. : 82115-2-RR

Synonyme

SLC7A11, xCT, 230227C5, Amino acid transport system xc, Amino acid transport system xc-



Geprüfte Anwendungen

Erfolgreiche Detektion in IF/ICCA549-Zellen
Erfolgreiche Detektion in FC (Intra)A549-Zellen, HeLa-Zellen

Empfohlene Verdünnung

AnwendungVerdünnung
Immunfluoreszenz (IF)/ICCIF/ICC : 1:125-1:500
Durchflusszytometrie (FC) (INTRA)FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

WBSee 2 publications below
IFSee 1 publications below

Produktinformation

82115-2-RR bindet in WB, IF/ICC, FC (Intra), ELISA SLC7A11/xCT und zeigt Reaktivität mit human

Getestete Reaktivität human
In Publikationen genannte Reaktivitäthuman, Maus
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen SLC7A11/xCT fusion protein Ag25431
Vollständiger Name solute carrier family 7, (cationic amino acid transporter, y+ system) member 11
Berechnetes Molekulargewicht 55 kDa
GenBank-ZugangsnummerBC012087
Gene symbol SLC7A11
Gene ID (NCBI) 23657
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS with 0.02% sodium azide and 50% glycerol
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

SLC7A11 (also known as xCT) is a membrane transporter involved in the uptake of cystine. It promotes glutathione synthesis through the uptake of cystine and the concomitant release of glutamate. This, in turn, protects cells from oxidative stress, maintains cellular redox balance, and prevents cell death induced by lipid peroxidation. SLC7A11 has been identified as a potential target for cancer therapeutics. It is overexpressed in multiple malignant tumors and is closely associated with the growth, prognosis, metastasis, and treatment response of various cancers including lung cancer.

Protokolle

PRODUKTSPEZIFISCHE PROTOKOLLE
IF protocol for SLC7A11/xCT antibody 82115-2-RRProtokoll herunterladen
FC protocol for SLC7A11/xCT antibody 82115-2-RRDownload protocol
STANDARD-PROTOKOLLE
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanWB

Front Immunol

A disulfidptosis-related lncRNA signature for analyzing tumor microenvironment and clinical prognosis in hepatocellular carcinoma

Authors - Haishui Zheng
humanWB

Biofactors

Induction of UBQLN1-mediated PGC1α stability by isoliensinine overcame hypoxia-induced resistance in liver cancer cells

Authors - Xuefen Xu
mouseIF

Ren Fail

Dapagliflozin improves diabetic kidney disease by inhibiting ferroptosis through β-hydroxybutyrate production

Authors - Yan Tian